Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Inclusion Criteria: * Have moderate to severe levels of facial lipoatrophy determined by the three investigstors * If female of child-bearing potential (not menopausal for at least 1 year nor surgically sterile), have a negative urine pregnancy test prior to any study treatments and be willing to use oral contraception or another medically acceptable form of contraception for the duration of the study * Be able to understand and comply with the requirements of this study * Be willing and able to provide written Informed Consent prior to any study-related procedures being performed * Agree to refrain from seeking other treatment for lipoatrophy in the facial area while participating in this study Exclusion Criteria: * Are pregnant, lactating, or trying to become pregnant * Had prior therapy (e.g., other permanent or biodegradable injectable fillers or surgical correction such as a face-lift, etc.) within 9 months prior to entry into the study or are planning to undergo such therapy during the study * Have any active inflammation, infection, or unhealed wound of the face * Have any contraindicated condition described in the package insert for the product to be administered. * Have a history of anaphylaxis or multiple severe allergies. * Have planned relocation during the study, which would make follow-up visits impossible during the course of the study * Used aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) within 1 week prior to initial or touch-up treatment or are …